Malaria Diagnostics Market is a serious life-threatening disease caused by a parasite, transmitted by the bite of infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium parasite. When the infected mosquito bites you, the parasite is released into your bloodstream. Once the human body becomes the host for the parasite it travels to the liver and matures. After some days, the mature parasite enters the bloodstream and starts to infect red blood cells (RBC). Humans suffering from malaria frequently experience fever, headache, weakness, vomiting
The global malaria diagnostics market is expected to register a significant growth of 4.6 % CAGR during the forecast period (2018–2023)
However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market. The weak regulatory framework and lack of awareness across the emerging nations is a prime concern for the manufacturers and healthcare providers. The absence of strong import export guidelines can lead to the use of substandard products that can lead to additional complications for patients. Besides, the long registration procedures, the market entry parameters must be assessed carefully for investment considerations.
Get Sample For this Report at: https://www.marketresearchfuture.com/sample_request/6432
Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.
Global Malaria Diagnostics Market, by Technique
- Rapid diagnostic tests
- Molecular diagnostic tests
- Polymerase chain reaction (PCR)
- Real-time polymerase chain reaction (RT-PCR)
Global Malaria Diagnostics Market, by End-Users
- Community healthcare
Primary and precise diagnosis of malaria is essential for both fast and effective disease management and observation. Superior quality malaria diagnosis systems are important in all settings as misdiagnosis or misinterpretation can result in substantial morbidity and mortality. World Health Organization (WHO) recommends a quick malaria diagnosis either by microscopy or malaria rapid diagnostic test (RDT) in all patients with suspected malaria before treatment is being administered. Diagnostic testing improves the overall management of patients with febrile illnesses and may also help to decrease the emergence and spread of drug resistance by storing antimalarials for those who have the disease.
Brows Full Report at: https://www.marketresearchfuture.com/reports/malaria-diagnostics-market-6432
Geographically, Malaria Diagnostics Market segmented into
Americas is projected to lead the malaria diagnostics market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.
The European market is expected to hold the second largest market share. The European market is projected to grow because of the malaria cases brought in the European region by tourists and refugees. The European Centre for Disease Prevention and Control, stats reported a range of 5000 -7000 cases of malaria from 2008 to 2012.
Asia-Pacific is projected to be the fastest growing region for the global malaria diagnostics market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. The diagnostic testing market, by volume, in India is controlled by microscopy testing. With increasing awareness and growing funding from care-based surveillance systems, private sectors and national governments the necessity for diagnostic testing procedures are projected to rise, thereby boosting the market development.
Enquire for Discount at: https://www.marketresearchfuture.com/check-discount/6432
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. Southeast Asia accounted for about 10% of the global cases, however, the death rate was around 7% in the same year.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312